Thomas F. Lüscher, MD, FRCP Professor of Cardiology, Imperial College and Director of Research, Education and Development, Royal Brompton and Harefield Hospital, London, UK Chairman, Center for Molecular Cardiology, University Zurich, Switzerland Covid-19 – in the End an Endothelial Disease Biomarkers & Personalized Medicine in Cardiology 2021
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Thomas F. Lüscher, MD, FRCP Professor of Cardiology, Imperial College and Director of Research, Education
and Development, Royal Brompton and Harefield Hospital, London, UK
Chairman, Center for Molecular Cardiology, University Zurich, Switzerland
Covid-19 – in the End an Endothelial Disease
Biomarkers & Personalized
Medicine in Cardiology
2021
1.Un (un-)expected Pandemic
2.A Lung Disease
3.Only a Lung Disease?
4.Covid-19 is in the end an Endothelial Disease
5.Covid-19 and Cardiac Injury and Disease
6.CV Collateral Damage of Covid-10
7.Post Covid Disease
On December 30th Dr. Li Wenliang warns of
a new Corona Virus causing Pneumonia
1.Un (un-)expected Pandemic
2.A Lung Disease
3.Only a Lung Disease?
4.Covid-19 is in the end an Endothelial Disease
5.Covid-19 and Cardiac Injury and Disease
6.CV Collateral Damage of Covid-10
7.Post Covid Disease
Lung CT Presentation of Covid-19
Typical Features: Multiple bilateral lobular and subsegmental areas of
groundglass opacity or consolidationa, crazy-paving pattern, air bronchograms,
reverse halo/perilobular pattern.
Atypical features: interlobular or septal thickening (smooth or irregular),
thickening of the adjacent pleura, subpleural involvement, pleural effu-sion,